The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging

scientific article published on November 2004

The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/SIM.1909
P8608Fatcat IDrelease_nxftk2rdxjailb7spp6u644gvu
P698PubMed publication ID15490432

P50authorNick C. FoxQ37836499
Michael G. KenwardQ58619221
Chris FrostQ84173613
P2860cites workClinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
P433issue21
P407language of work or nameEnglishQ1860
P304page(s)3275-3286
P577publication date2004-11-01
P1433published inStatistics in MedicineQ7604438
P1476titleThe analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging
P478volume23

Reverse relations

cites work (P2860)
Q33726079A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
Q36251868Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge
Q33540910Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease
Q36661880Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration
Q48414068Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials
Q33565800Comparison of phantom and registration scaling corrections using the ADNI cohort
Q47866122Deep grey matter volume loss drives disability worsening in multiple sclerosis.
Q45304194Design optimization for clinical trials in early-stage manifest Huntington's disease
Q47265537Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates
Q29012779Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
Q36167476Estimating anatomical trajectories with Bayesian mixed-effects modeling
Q34081836In vivo evidence of glutamate toxicity in multiple sclerosis
Q91969017Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Q33766180Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type
Q61910897MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration
Q37258575MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset
Q33759240Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals
Q34457231Now you hear it, now you don't: transient traces of consonants and their nonspeech analogues in the human brain
Q47342494Patterns of progressive atrophy vary with age in Alzheimer's disease patients.
Q39138281Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
Q53032916Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.
Q30354417Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
Q33384098Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis
Q34081087Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Q48417159Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study
Q48457345Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations

Search more.